Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-05 Sale |
2024-02-06 6:26 pm |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
19,642 | $4.86 | $95,460 | 1,144,601 (Indirect Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 7:00 pm |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
18,338 | $4.95 | $90,773 | 434,443 (Indirect Direct) |
View |
| 2023-08-30 Purchase |
2023-09-05 08:27 am |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
6,500 | $3.81 | $24,765 | 452,781 (Indirect Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:29 pm |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
19,669 | $4.24 | $83,397 | 446,281 (Direct) |
View |
| 2021-08-20 Purchase |
2021-08-24 08:49 am |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
5,000 | $9.89 | $49,450 | 102,900 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-20 Option Award |
2024-06-24 4:09 pm |
N/A 2034-06-20 |
Aura Biosciences Inc. | AURA | Mattessich Antony C. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-02-03 Option Award |
2024-02-06 6:26 pm |
N/A 2034-02-02 |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
729,800 | $0 | 1,144,601 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:57 pm |
N/A 2033-06-07 |
Aura Biosciences Inc. | AURA | Mattessich Antony C. Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 7:32 pm |
N/A 2033-01-29 |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
713,200 | $0 | 1,002,850 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:06 pm |
N/A 2032-06-15 |
Aura Biosciences Inc. | AURA | Mattessich Antony C. Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-07 7:28 pm |
N/A 2032-02-02 |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
746,950 | $0 | 849,850 (Direct) |
View |
| 2021-10-28 Option Award |
2021-10-29 7:27 pm |
N/A 2031-10-27 |
Aura Biosciences Inc. | AURA | Mattessich Antony C. Director |
16,000 | $0 | 16,000 (Direct) |
View |
Ownership |
2021-10-28 8:22 pm |
N/A 2031-09-22 |
Aura Biosciences Inc. | AURA | Mattessich Antony C. Director |
0 | $0 | 53,649 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 4:30 pm |
N/A 2031-02-16 |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
455,000 | $0 | 455,000 (Direct) |
View |